8-K
Current Report
Avalo Therapeutics, Inc. Filed Acc 0001628280-24-029564
Executive or director change · Other events
- Item 5.02 Departure or appointment of directors or officers
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading avtx-20240624.htm…